Loading…
Based on limited metadata with no full letter text available, this warning letter was issued to Triad Rx, Inc. on February 5, 2019, regarding a product classified as "Other." Without access to the specific subject line or detailed violation information, the exact nature of the regulatory concerns cannot be determined. The letter represents FDA enforcement action, though the specific issuing office and number of violations are not specified in the available metadata. To understand the full scope of violations and required corrective actions, the complete warning letter text would be needed.